Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of bevacizumab in advanced low grade serous ovarian cancer: Data from the MITO 22 trial.
Musacchio L, Turinetto M, Arenare L, Bartoletti M, Califano D, Tuninetti V, Marchetti C, Cormio G, Loizzi V, Pisano C, Salutari V, Valabrega G, Priolo D, Cecere SC, Ventriglia J, Raspagliesi F, Perrone F, Fagotti A, Lorusso D, Scambia G, Pignata S. Musacchio L, et al. Among authors: valabrega g. Gynecol Oncol. 2023 May;172:72-77. doi: 10.1016/j.ygyno.2023.03.011. Epub 2023 Mar 23. Gynecol Oncol. 2023. PMID: 36965291
Trastuzumab treatment in breast cancer.
Montemurro F, Valabrega G, Aglietta M. Montemurro F, et al. Among authors: valabrega g. N Engl J Med. 2006 May 18;354(20):2186; author reply 2186. doi: 10.1056/NEJMc060852. N Engl J Med. 2006. PMID: 16707759 No abstract available.
Moderate immunohistochemical expression of HER-2 (2+) without HER-2 gene amplification is a negative prognostic factor in early breast cancer.
Rossi V, Sarotto I, Maggiorotto F, Berchialla P, Kubatzki F, Tomasi N, Redana S, Martinello R, Valabrega G, Aglietta M, Ponzone R, Montemurro F. Rossi V, et al. Among authors: valabrega g. Oncologist. 2012;17(11):1418-25. doi: 10.1634/theoncologist.2012-0194. Epub 2012 Sep 4. Oncologist. 2012. PMID: 22951668 Free PMC article.
Trastuzumab beyond disease progression: case closed?
Valabrega G, Aglietta M, Montemurro F. Valabrega G, et al. J Clin Oncol. 2009 Sep 20;27(27):e121-2; author reply e124-5. doi: 10.1200/JCO.2009.23.8873. Epub 2009 Aug 17. J Clin Oncol. 2009. PMID: 19687323 No abstract available.
Modeling ErbB2-p130Cas interaction to design new potential anticancer agents.
Costamagna A, Rossi Sebastiano M, Natalini D, Simoni M, Valabrega G, Defilippi P, Visentin S, Ermondi G, Turco E, Caron G, Cabodi S. Costamagna A, et al. Among authors: valabrega g. Sci Rep. 2019 Feb 28;9(1):3089. doi: 10.1038/s41598-019-39510-w. Sci Rep. 2019. PMID: 30816273 Free PMC article.
113 results